Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Interplay between Candida albicans and the antimicrobial peptide armory.

Swidergall M, Ernst JF.

Eukaryot Cell. 2014 Aug;13(8):950-7. doi: 10.1128/EC.00093-14. Epub 2014 Jun 20. Review.

2.

Looking into Candida albicans infection, host response, and antifungal strategies.

Wang Y.

Virulence. 2015;6(4):307-8. doi: 10.1080/21505594.2014.1000752. Epub 2015 Jan 15.

3.

Interplay between Candida albicans and the mammalian innate host defense.

Cheng SC, Joosten LA, Kullberg BJ, Netea MG.

Infect Immun. 2012 Apr;80(4):1304-13. doi: 10.1128/IAI.06146-11. Epub 2012 Jan 17. Review.

4.

Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota.

Höfs S, Mogavero S, Hube B.

J Microbiol. 2016 Mar;54(3):149-69. doi: 10.1007/s12275-016-5514-0. Epub 2016 Feb 27. Review.

PMID:
26920876
5.

SSD1 is integral to host defense peptide resistance in Candida albicans.

Gank KD, Yeaman MR, Kojima S, Yount NY, Park H, Edwards JE Jr, Filler SG, Fu Y.

Eukaryot Cell. 2008 Aug;7(8):1318-27. doi: 10.1128/EC.00402-07. Epub 2008 May 30.

6.

Pathogenesis of Candida albicans biofilm.

Tsui C, Kong EF, Jabra-Rizk MA.

Pathog Dis. 2016 Jun;74(4):ftw018. Review.

7.

Innate immune cell response upon Candida albicans infection.

Qin Y, Zhang L, Xu Z, Zhang J, Jiang YY, Cao Y, Yan T.

Virulence. 2016 Jul 3;7(5):512-26. doi: 10.1080/21505594.2016.1138201. Epub 2016 Apr 14. Review.

8.

A histone deacetylase complex mediates biofilm dispersal and drug resistance in Candida albicans.

Nobile CJ, Fox EP, Hartooni N, Mitchell KF, Hnisz D, Andes DR, Kuchler K, Johnson AD.

MBio. 2014 Jun 10;5(3):e01201-14. doi: 10.1128/mBio.01201-14.

9.

Complexity and dynamics of host-fungal interactions.

Cottier F, Pavelka N.

Immunol Res. 2012 Sep;53(1-3):127-35. doi: 10.1007/s12026-012-8265-y. Review.

PMID:
22415250
10.

Complement and innate immune evasion strategies of the human pathogenic fungus Candida albicans.

Luo S, Skerka C, Kurzai O, Zipfel PF.

Mol Immunol. 2013 Dec 15;56(3):161-9. doi: 10.1016/j.molimm.2013.05.218. Epub 2013 Jun 26. Review.

PMID:
23809232
11.

Antifungal activity of cathelicidin peptides against planktonic and biofilm cultures of Candida species isolated from vaginal infections.

Scarsini M, Tomasinsig L, Arzese A, D'Este F, Oro D, Skerlavaj B.

Peptides. 2015 Sep;71:211-21. doi: 10.1016/j.peptides.2015.07.023. Epub 2015 Jul 31.

PMID:
26238597
12.

Candida albicans drug resistance another way to cope with stress.

Cannon RD, Lamping E, Holmes AR, Niimi K, Tanabe K, Niimi M, Monk BC.

Microbiology. 2007 Oct;153(Pt 10):3211-7. Review.

PMID:
17906120
13.

Therapeutic use of a cationic antimicrobial peptide from the spider Acanthoscurria gomesiana in the control of experimental candidiasis.

Rossi DC, Muñoz JE, Carvalho DD, Belmonte R, Faintuch B, Borelli P, Miranda A, Taborda CP, Daffre S.

BMC Microbiol. 2012 Mar 6;12:28. doi: 10.1186/1471-2180-12-28.

14.

β-Defensin 1 plays a role in acute mucosal defense against Candida albicans.

Tomalka J, Azodi E, Narra HP, Patel K, O'Neill S, Cardwell C, Hall BA, Wilson JM, Hise AG.

J Immunol. 2015 Feb 15;194(4):1788-95. doi: 10.4049/jimmunol.1203239. Epub 2015 Jan 16.

15.

Anti-fungal activity of cathelicidins and their potential role in Candida albicans skin infection.

López-García B, Lee PH, Yamasaki K, Gallo RL.

J Invest Dermatol. 2005 Jul;125(1):108-15.

16.

Antifungal susceptibility of Candida albicans in biofilms.

Tobudic S, Kratzer C, Lassnigg A, Presterl E.

Mycoses. 2012 May;55(3):199-204. doi: 10.1111/j.1439-0507.2011.02076.x. Epub 2011 Jul 28. Review.

PMID:
21793943
17.

Horizontal transmission of Candida albicans and evidence of a vaccine response in mice colonized with the fungus.

Cutler JE, Corti M, Lambert P, Ferris M, Xin H.

PLoS One. 2011;6(7):e22030. doi: 10.1371/journal.pone.0022030. Epub 2011 Jul 19.

18.

Hydrophobicity and helicity regulate the antifungal activity of 14-helical β-peptides.

Lee MR, Raman N, Gellman SH, Lynn DM, Palecek SP.

ACS Chem Biol. 2014 Jul 18;9(7):1613-21. doi: 10.1021/cb500203e. Epub 2014 Jun 2.

19.

Melanocytes and melanin represent a first line of innate immunity against Candida albicans.

Tapia CV, Falconer M, Tempio F, Falcón F, López M, Fuentes M, Alburquenque C, Amaro J, Bucarey SA, Di Nardo A.

Med Mycol. 2014 Jul;52(5):445-54. doi: 10.1093/mmy/myu026. Epub 2014 Jun 15.

PMID:
24934806
20.

Host responses to a versatile commensal: PAMPs and PRRs interplay leading to tolerance or infection by Candida albicans.

Jouault T, Sarazin A, Martinez-Esparza M, Fradin C, Sendid B, Poulain D.

Cell Microbiol. 2009 Jul;11(7):1007-15. doi: 10.1111/j.1462-5822.2009.01318.x. Epub 2009 Mar 18. Review.

PMID:
19388906

Supplemental Content

Support Center